Amanote Research
Register
Sign In
Canakinumab Therapy in Patients With Familial Mediterranean Fever
Pediatric Rheumatology
- United Kingdom
doi 10.1186/1546-0096-13-s1-o45
Full Text
Open PDF
Abstract
Available in
full text
Categories
Immunology
Pediatrics
Rheumatology
Allergy
Perinatology
Child Health
Date
September 28, 2015
Authors
S Ugurlu
E Seyahi
G Hatemi
A Hacioglu
H Ozcan
FN Akkoc
H Ozdogan
Publisher
Springer Science and Business Media LLC
Related search
Treatment of Familial Mediterranean Fever With Canakinumab in Patients Who Are Unresponsive to Colchicine
European Journal of Rheumatology
Assessment of Effectiveness of Anakinra and Canakinumab in Patients With Colchicine-Resistant/Unresponsive Familial Mediterranean Fever
Advances in Rheumatology
Rheumatology
Common MEFV Mutations in Palestinian Patients With Familial Mediterranean Fever
International Journal of Genetics and Genomics
Non-Periodic Leg Pain in Patients With Familial Mediterranean Fever
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Rapidly Progressive Creutzfeldt-Jakob Disease in Patients With Familial Mediterranean Fever
European Journal of Neurology
Neurology
Endoscopic Findings in Patients With Familial Mediterranean Fever and Dyspeptic Symptoms
Przeglad Gastroenterologiczny
Gastroenterology
Canakinumab as Monotherapy for Treatment of Familial Mediterranean Fever – First Report in Central and Eastern Europe Region
Bratislava Medical Journal
Familial Mediterranean Fever With Small Bowel Stenosis
Internal Medicine
Internal Medicine
Medicine
Biopsy Proven Non-Amyloid Glomerular Diseases in Patients With Familial Mediterranean Fever
Journal of Nephrology Research
